ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 720447 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 720447; 2) Community: the network communities that were significantly associated with the response to NSC 720447; 3) Molecule: the relationships between components within communities and NSC 720447; 4) MDR: the compounds that were significantly associated with the NSC 720447.

NSC Compound Enrichment Correlation
NSC 140873 2-Amino-N-(4-chloro-2-(1H-pyrrole-2-carbonyl)phenyl)acetamide 0.0430505868034761 -0.31314717
NSC 166199 Phosphinic amide, P,P-bis(1-aziridinyl)-N-tricyclo[3.3.1.1(3.7)]dec-1-yl- (9CI) 0.0430505868034761 -0.10587409
NSC 176323 Camptothecin Derivative 0.0430505868034761 -0.049448956
NSC 201459 1H-Indol-2-one, 5-bromo-2,3-dihydro-3-[[(4-methoxyphenyl) carbonyl]methylene]- 0.0430505868034761 -0.34326145
NSC 270057 Hydroxypristimerin 0.0430505868034761 -0.27636143
NSC 287069 Epicorazine A 0.0430505868034761 -0.37840343
NSC 295499 Camptothecin Derivative 0.0430505868034761 -0.18524493
NSC 31780 3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) 0.0430505868034761 -0.2236781
NSC 337851 Pregna-1,4-diene-3,11,20-trione, 21-[[[[3,6-bis(dimethylamino)-9-acridinyl]thio]acetyl]oxy]-17-hydroxy- 0.0430505868034761 -0.4619024
NSC 359415 Null 0.0430505868034761 -0.27604208
Total:109  Current:96    [First] [Prev] [Next] [Last]